Back to Journals » Clinical Ophthalmology » Volume 4

Acrylic toric intraocular lens implantation: a single center experience concerning clinical outcomes and postoperative rotation

Authors Tsinopoulos IT, Tsaousis K, Tsakpinis D, Ziakas NG, Dimitrakos SA

Published 10 March 2010 Volume 2010:4 Pages 137—142


Review by Single anonymous peer review

Peer reviewer comments 2

Ioannis T Tsinopoulos1, Konstantinos T Tsaousis1, Dimitrios Tsakpinis1, Nikolaos G Ziakas2, Stavros A Dimitrakos1

12nd Department of Ophthalmology, Aristotle University of Thessaloniki, Papageorgiou General Hospital, Thessaloniki, Greece; 21st Department of Ophthalmology, Aristotle University of Thessaloniki, AHEPA General Hospital, Thessaloniki, Greece

Purpose: To present clinical results of toric intraocular lens (IOL) implantation for preexisting astigmatism correction and determine the time of any postoperative rotation.

Patients and methods: Twenty-nine eyes of 19 patients underwent uncomplicated phacoemulsification and were implanted with an Acrysof© toric IOL. Uncorrected visual acuity, residual astigmatism, and postoperative rotation of the IOL were estimated one and six months after the operation.

Results: Uncorrected visual acuity was ≥0.5 in 26 of 29 eyes (89.7%) and ≥0.8 in 19 of 29 patients (65.5%). The mean toric IOL axis rotation was 2.2 ± 1.5° (range 0.6–7.8°) one month postoperation and 2.7 ± 1.5° (range 0.9–8.4°) six months postoperation.

Conclusion: Implantation of one-piece hydrophobic acrylic toric IOLs appears to have acceptable stability, which encourages visual outcome and emerges as an attractive alternative for correction of refractive astigmatism.

Keywords: astigmatism, cataract, stability, implantation

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.